Zepp Health Files 2023 Annual Report Amendment

Ticker: ZEPP · Form: 20-F/A · Filed: Jun 27, 2024 · CIK: 1720446

Sentiment: neutral

Topics: amendment, annual-report, sec-filing

TL;DR

Zepp Health amended its 2023 annual report, check for updated financials and disclosures.

AI Summary

Zepp Health Corp filed an amendment (20-F/A) to its annual report for the fiscal year ended December 31, 2023. The filing, submitted on June 27, 2024, provides updated information regarding the company's operations and financial status. Zepp Health Corp, formerly known as Huami Corp, is incorporated in E9 and headquartered in Hefei, China.

Why It Matters

This amendment provides updated disclosures for the fiscal year 2023, which is crucial for investors to assess the company's current financial health and strategic direction.

Risk Assessment

Risk Level: medium — Amendments to annual reports can indicate a need for clarification or correction of previously filed information, potentially signaling underlying issues.

Key Numbers

Key Players & Entities

FAQ

What specific information was amended in the 20-F/A filing?

The filing is an amendment to the annual report for the fiscal year ended December 31, 2023, indicating that updates or corrections were made to the original filing.

When was this amendment filed with the SEC?

The amendment was filed on June 27, 2024.

What is Zepp Health Corp's former name?

Zepp Health Corp was formerly known as Huami Corp, with a date of name change on October 23, 2017.

Where is Zepp Health Corp headquartered?

Zepp Health Corp is headquartered in Hefei, China, with its business address at Building B2, Zhong'an Chuanggu, Technology Park No.900 Wangjiang West Rd.

What is the SIC code for Zepp Health Corp?

The Standard Industrial Classification (SIC) code for Zepp Health Corp is 3571, which corresponds to Electronic Computers.

Filing Stats: 4,500 words · 18 min read · ~15 pages · Grade level 15.8 · Accepted 2024-06-27 06:07:40

Key Financial Figures

Filing Documents

FINANCIAL

ITEM 18. FINANCIAL 1

EXHIBITS

ITEM 19. EXHIBITS 2 i PART III

FINANCIAL STATEMENTS

ITEM 18. FINANCIAL STATEMENTS The following financial statements are included in this Form 20-F/A: Consolidated financial statements of Jiangsu Yitong High-tech Co., Ltd. as of December 31, 2022 and 2023 and for the fiscal years ended December 31, 2021, 2022 and 2023. 1 JIANGSU YITONG HIGH-TECH CO., LTD TABLE OF CONTENTS INDEX TO CONSOLIDATED FINANCIAL STATEMENTS Page Report of Independent Registered Public Accounting Firm F-2 Consolidated Balance Sheets as of December 31, 2022 and 2023 F-4 Consolidated F-6 Consolidated F-7 Consolidated F-8 Notes to Consolidated Financial Statements F-10 F-1 REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the Board of Directors of Jiangsu Yitong High-tech Co., Ltd We have audited the accompanying consolidated balance sheets of Jiangsu Yitong High-tech Co., Ltd. and its subsidiaries (the "Company") as of December 31, 2023, the related consolidated statements of operations, changes in equity, and cash flows for the year ended December 31, 2023 and the related notes. Management's Responsibility for the Consolidated Financial Statements Management is responsible for the preparation and fair presentation of the consolidated financial statements in accordance with accounting principles generally accepted in the United States of America; this includes the design, implementation, and maintenance of internal control relevant to the preparation and fair presentation of consolidated financial statements that are free from material misstatement, whether due to fraud or error. Convenience translation Our audit also comprehended the translation of Renminbi amounts into United States dollar amounts and, in our opinion, such translation has been made in conform

View Full Filing

View this 20-F/A filing on SEC EDGAR

View on Read The Filing